Business & Finance

Bayer AG, the chemical/pharmaceutical giant, vaulted into the top three in the over-the-counter medications market by agreeing to buy Roche Consumer Health, the nonprescription drug subsidiary of Switzerland's Roche Holding. The sale price was reported to be $2.97 billion. The deal does not include Roche's over-the-counter business in Japan, reported. The over-the-counter industry leaders are Pfizer Inc. and Johnson & Johnson, both of the US.

In a deal valued at $1.05 billion, the No. 2 bank in Portugal said it will sell its insurance subsidiaries to larger rival Caixa Geral de Depositos SA and to Fortis, the Belgian financial-services giant. Banco Comercial Português SA had tried to unload the insurance units for two years to concentrate on retail banking, reported.

You've read  of  free articles. Subscribe to continue.
QR Code to Business & Finance
Read this article in
QR Code to Subscription page
Start your subscription today